There are no significant differences in outcomes post-AMI in patients with systemic lupus erythematosus vs the general population.

To the Editor: In their report, in the August 7 issue of the Journal, of 14 patients with "Systemic Lupus Erythematosus Simulating Acute Surgical Condition of the Abdomen," Pollak et al.

He also reported that complete remission of the cutaneous lesions without sequelae seemed inconceivable, given the severe disfigurement during the acute phase. However, in the initial months, the ...

Systemic Lupus Erythematosus (SLE): Around 70% of people with lupus have this type. It causes acute and chronic inflammation to a number of organs and organ systems. Cutaneous Lupus (lupus skin ...

Silverlon®, a silver-plated burn and wound care dressing, is now indicated for managing acute cutaneous radiation injuries (CRIs), including moist desquamation, without full-thickness skin ...

Acute chest syndrome is a serious complication of sickle cell disease. It involves symptoms like chest pain, cough, or fever and can be life threatening if not treated promptly. Sickle cell ...

The patient with the co-infection had no previous negative test result for SARS-CoV-2 that would ascertain the duration of the infection; nevertheless, the viral sequences indicated an acute infection ...

USA: A recent pilot study, published in the Journal of the American Academy of Dermatology has shown that a combination topical cream containing 5% 5-fluorouracil and 0.005% calcipotriene is ...

Sept 30 (Reuters) - Kezar Life Sciences (KZR.O), opens new tab said on Monday it has paused a trial of its experimental drug for lupus to review safety data after four patients died in the mid ...

a kidney disease-related complication of systemic lupus erythematosus. Patients were dosed with either 30 mg of zetomipzomib, 60 mg of zetomipzomib or placebo and standard background therapy.

The Subacute Cutaneous Lupus Erythematosus (SCLE) drugs in development market research report provides comprehensive information on the therapeutics under development for Subacute Cutaneous Lupus ...